| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spruce Biosciences, Inc. (SPRB) has 13 insiders with recent SEC Form 4 filings, including 4 buys and 10 sells. SPRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 30.0K | $1.70M | - | |
| ? | 30.0K | $1.70M | - | |
| CEO | Szwarcberg Javier B. | 19.0K | $1.08M | - |
| CFO | Gharib Samir M. | 8.3K | $467.4K | - |
| CFO | 7.6K | $430.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 257 | $19.14 | $4,920.12 | -10.8% | -37.0% | - | |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 257 | $19.14 | $4,920.12 | -10.8% | -37.0% | - | |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy | 256 | $17.91 | $4,585.16 | +24.4% | -37.0% | - | |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy | 256 | $17.91 | $4,585.16 | +24.4% | -37.0% | - | |
| Mar 21, 2024 | Novo Holdings A/s58 | 10% Owner | Sell | 465,021 | $0.75 | $350,951.35 | -15.4% | -29.9% | -55.4% | |
| Mar 20, 2024 | Novo Holdings A/s58 | 10% Owner | Sell | 1,794,999 | $0.76 | $1,358,803.76 | -14.8% | -15.4% | -54.9% | |
| Mar 14, 2024 | Novo Holdings A/s58 | 10% Owner | Sell | 1,912,316 | $0.89 | $1,698,901.53 | -28.4% | -18.0% | -58.7% | |
| Feb 16, 2023 | Novo Holdings A/s58 | 10% Owner | Buy | 2,208,000 | $3.17 | $6,999,360.00 | +48.9% | -8.4% | +100.0% | |
| Feb 16, 2023 | O'Donnell Niall | Director | Buy | 630,400 | $3.17 | $1,998,368.00 | +90.6% | -8.4% | +100.0% | |
| May 20, 2021 | Simpson Camilla V | Director | Sale+OE | 334 | $15.29 | $5,106.86 | -100% | -46.2% | -91.1% |